FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight

The Federal Trade Commission on Tuesday announced it has submitted a comment backing the U.S. Patent and Trademark Office’s recently proposed changes to the way it reviews patent disputes, enabling greater antitrust oversight over pharmaceutical drug settlements.